PRESCIENT THERAPEUTICS LIMITED — Director's Dealing 2006

Apr 12, 2006

Notice of Change of Director's Interest (Appendix 3Y Notice) Notice No. 06

Name of entity:	Virax Holdings Limited
ABN No:	56 006 569 106

We, Virax Holdings Limited, give ASX the following information under listing rule 3.19A.1 and as agent for the Director for the purposes of section 205G of the Corporation Act.

Name of Director	Dr David J Beames
Date of last notice	$\vert$ 25 January 2006	Last Notice No 05

Part 1 - Change of Director's relevant interest in securities*

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of thecircumstances giving rise tothe relevant interest	Beneficiary of Equitech Corporation Pty Ltd (ATF The EquitechSuperannuation Fund) and;Beneficiary of Equitech Corporation Pty Ltd (ATF The BC InvestmentTrust)
Date of change	3 April 2006
Class	Fully PaidOrdinary Share	Partly PaidOrdinary Share	Option
No. of securities held priorto change	1,220,000	Nil	1,250,000 Unlisted66,667 Listed VHLOB
Number acquired	200,000	Nil
Number disposed	Nil	Nil.	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation	$0.075 per share	Nil	Nil
No. of securities held afterchange	1,420,000	Nil	1,250,000 Unlisted66,667 Listed VHLOB
Nature of changeExample: on-market trade,off-market trade, exercise ofoptions, issue of securitiesunder dividend reinvestmentplan, participation in buy-back	Payment of final installment on partly paid shares purchased pursuantto participation in Non-Renounceable Pro Rate Rights Issue.

Notice of Change of Director's Interest (Appendix 3Y Notice) Notice No. 06

Part 2 – Change of Director's interests in contracts*

Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which interestrelated prior to change:
Note: Details are only required for a contractin relation to which the interest has changed.
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, providedetails and estimated valuation
Interest after change

$\star$ If insufficient space please provide attachment and insert attachment number in appropriate space.

Signed

Richard de Nantour

12 April 2006

Date

Richard de Lautour Company Secretary Virax Holdings Limited